Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 12
Submit an article Journal homepage
733
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Searching the central nervous system for relapsed acute promyelocytic leukemia

Eytan M. SteinLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
&
Martin S. TallmanLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Pages 2584-2585 | Published online: 12 May 2013

References

  • Iland HJ, Bradstock K, Supple SG, et al. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood 2012;120:1570–1580; quiz 1752.
  • Ravandi F, Estey E, Jones D, et al. Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. J Clin Oncol 2009;27:504–510.
  • Lo-Coco F, Avvisati G, Orlando SM, et al. ATRA and arsenic trioxide (ATO) versus ATRA and idarubicin (AIDA) for newly diagnosed, non high-risk acute promyelocytic leukemia (APL): results of the phase III, prospective, randomized, intergroup APL0406 study by the Italian-German cooperative groups GIMEMA-SAL-AMLSG. Blood 2012;120(Suppl. 1): Abstract 6.
  • Gupta V, Gonsalves W, Patnaik M, et al. Central nervous system relapse in acute promyelocytic leukemia: a single institution experience. Leuk Lymphoma 2013;54:2728–2730.
  • Specchia G, Lo Coco F, Vignetti M, et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell’Adulto. J Clin Oncol 2001;19:4023–4028.
  • de Botton S, Sanz MA, Chevret S, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 2006;20:35–41.
  • Montesinos P, Diaz-Mediavilla J, Deben G, et al. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica 2009;94:1242–1249.
  • Montesinos P, Rayon C, Vellenga E, et al. Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood 2011;117:1799–1805.
  • Breccia M, Petti MC, Testi AM, et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated “sanctuary”?Leukemia 2002;16:1127–1130.
  • Knipp S, Gattermann N, Schapira M, et al. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Leuk Res 2007;31:1585–1587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.